Évaluation de l’activité anxiolytique de la 4-phenyl-1,5-benzodiazepin-2-one
暂无分享,去创建一个
[1] F. Bonnet. Pharmacologie de la douleur , 2006 .
[2] D. Widlöcher. Dépression et anxiété , 2002 .
[3] Léon,et al. Guide de thérapeutique , 2008 .
[4] F. Graeff,et al. Anxiolytic effect of intra-amygdala injection of midazolam and 8-hydroxy-2-(di-n-propylamino)tetralin in the elevated T-maze. , 1999, European journal of pharmacology.
[5] J. Gerven,et al. Integrated pharmacokinetics and pharmacodynamics of Ro 48-8684, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects. , 2003, British journal of clinical pharmacology.
[6] S. File,et al. Evidence against oppositional and pharmacokinetic mechanisms of tolerance to diazepam's sedative effects , 1996, Brain Research.
[7] M. Tsuda,et al. Involvement of the opioid system in the anxiolytic effect of diazepam in mice. , 1996, European journal of pharmacology.
[8] S. Hogg. A review of the validity and variability of the Elevated Plus-Maze as an animal model of anxiety , 1996, Pharmacology Biochemistry and Behavior.
[9] C. Remy. Clobazam in the Treatment of Epilepsy: A Review of the Literature , 1994, Epilepsia.
[10] F. Graeff,et al. Ethopharmacological analysis of rat behavior on the elevated plus-maze , 1994, Pharmacology Biochemistry and Behavior.
[11] T. Fukuda,et al. The pharmacological properties of Y‐23684, a benzodiazepine receptor partial agonist , 1994, British journal of pharmacology.
[12] J. Medina,et al. Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora Coerulea , 1994, Pharmacology Biochemistry and Behavior.
[13] M. Juliano,et al. Tolerance to anticonvulsant effects of clobazam, diazepam, and clonazepam in genetically epilepsy prone rats. , 1992, Advances in biochemical psychopharmacology.
[14] C J Hull,et al. Pharmacokinetics and pharmacodynamics. , 1979, British journal of anaesthesia.